Procognia (Israel) Ltd holds a number of proprietary tools and technologies, representing some of the leading products for glycoanalysis of glycoprotein and oligosaccharides. Procognia also holds the worldwide exclusive license for an advanced high expression clone system.
| IP Portfolio | 9 patent families (63 patents/applications) 14 granted patents |
| Proprietary technology | Lectin arrays Algorithms Applications |
Worldwide exclusive license | High expression clone technology for biosimilar application |